Cargando…

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population

BACKGROUND: The BRCA1 and BRCA2 mutation spectrum and mutation detection rates according to different family histories were investigated in 521 subjects from 322 unrelated Slovenian cancer families with breast and/or ovarian cancer. METHODS: The BRCA1 and BRCA2 genes were screened using DGGE, PTT, H...

Descripción completa

Detalles Bibliográficos
Autores principales: Stegel, Vida, Krajc, Mateja, Žgajnar, Janez, Teugels, Erik, De Grève, Jacques, Hočevar, Marko, Novaković, Srdjan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025939/
https://www.ncbi.nlm.nih.gov/pubmed/21232165
http://dx.doi.org/10.1186/1471-2350-12-9
_version_ 1782196966716866560
author Stegel, Vida
Krajc, Mateja
Žgajnar, Janez
Teugels, Erik
De Grève, Jacques
Hočevar, Marko
Novaković, Srdjan
author_facet Stegel, Vida
Krajc, Mateja
Žgajnar, Janez
Teugels, Erik
De Grève, Jacques
Hočevar, Marko
Novaković, Srdjan
author_sort Stegel, Vida
collection PubMed
description BACKGROUND: The BRCA1 and BRCA2 mutation spectrum and mutation detection rates according to different family histories were investigated in 521 subjects from 322 unrelated Slovenian cancer families with breast and/or ovarian cancer. METHODS: The BRCA1 and BRCA2 genes were screened using DGGE, PTT, HRM, MLPA and direct sequencing. RESULTS: Eighteen different mutations were found in BRCA1 and 13 in BRCA2 gene. Mutations in one or other gene were found in 96 unrelated families. The mutation detection rates were the highest in the families with at least one breast and at least one ovarian cancer - 42% for BRCA1 and 8% for BRCA2. The mutation detection rate observed in the families with at least two breast cancers with disease onset before the age of 50 years and no ovarian cancer was 23% for BRCA1 and 13% for BRCA2. The mutation detection rate in the families with at least two breast cancers and only one with the disease onset before the age of 50 years was 11% for BRCA1 and 8% for BRCA2. In the families with at least two breast cancers, all of them with disease onset over the age of 50 years, the detection rate was 5% for BRCA2 and 0% for BRCA1. CONCLUSION: Among the mutations detected in Slovenian population, 5 mutations in BRCA1 and 4 mutations in BRCA2 have not been described in other populations until now. The most frequent mutations in our population were c.181T > G, c.1687C > T, c.5266dupC and c.844_850dupTCATTAC in BRCA1 gene and c.7806-2A > G, c.5291C > G and c.3978insTGCT in BRCA2 gene (detected in 69% of BRCA1 and BRCA2 positive families).
format Text
id pubmed-3025939
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30259392011-01-25 The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population Stegel, Vida Krajc, Mateja Žgajnar, Janez Teugels, Erik De Grève, Jacques Hočevar, Marko Novaković, Srdjan BMC Med Genet Research Article BACKGROUND: The BRCA1 and BRCA2 mutation spectrum and mutation detection rates according to different family histories were investigated in 521 subjects from 322 unrelated Slovenian cancer families with breast and/or ovarian cancer. METHODS: The BRCA1 and BRCA2 genes were screened using DGGE, PTT, HRM, MLPA and direct sequencing. RESULTS: Eighteen different mutations were found in BRCA1 and 13 in BRCA2 gene. Mutations in one or other gene were found in 96 unrelated families. The mutation detection rates were the highest in the families with at least one breast and at least one ovarian cancer - 42% for BRCA1 and 8% for BRCA2. The mutation detection rate observed in the families with at least two breast cancers with disease onset before the age of 50 years and no ovarian cancer was 23% for BRCA1 and 13% for BRCA2. The mutation detection rate in the families with at least two breast cancers and only one with the disease onset before the age of 50 years was 11% for BRCA1 and 8% for BRCA2. In the families with at least two breast cancers, all of them with disease onset over the age of 50 years, the detection rate was 5% for BRCA2 and 0% for BRCA1. CONCLUSION: Among the mutations detected in Slovenian population, 5 mutations in BRCA1 and 4 mutations in BRCA2 have not been described in other populations until now. The most frequent mutations in our population were c.181T > G, c.1687C > T, c.5266dupC and c.844_850dupTCATTAC in BRCA1 gene and c.7806-2A > G, c.5291C > G and c.3978insTGCT in BRCA2 gene (detected in 69% of BRCA1 and BRCA2 positive families). BioMed Central 2011-01-14 /pmc/articles/PMC3025939/ /pubmed/21232165 http://dx.doi.org/10.1186/1471-2350-12-9 Text en Copyright ©2011 Stegel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Stegel, Vida
Krajc, Mateja
Žgajnar, Janez
Teugels, Erik
De Grève, Jacques
Hočevar, Marko
Novaković, Srdjan
The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
title The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
title_full The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
title_fullStr The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
title_full_unstemmed The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
title_short The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
title_sort occurrence of germline brca1 and brca2 sequence alterations in slovenian population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025939/
https://www.ncbi.nlm.nih.gov/pubmed/21232165
http://dx.doi.org/10.1186/1471-2350-12-9
work_keys_str_mv AT stegelvida theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT krajcmateja theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT zgajnarjanez theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT teugelserik theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT degrevejacques theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT hocevarmarko theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT novakovicsrdjan theoccurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT stegelvida occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT krajcmateja occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT zgajnarjanez occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT teugelserik occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT degrevejacques occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT hocevarmarko occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation
AT novakovicsrdjan occurrenceofgermlinebrca1andbrca2sequencealterationsinslovenianpopulation